Saroja Pharma Industries India Limited, a active public limited company, was established on 14 January 2019 in Mumbai, Maharashtra, India. Engaging in chemical distribution & retail within the trade sector, it holds CIN: U24110MH2019PLC319508. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.02 Cr.
It upholds a compliant status. Its leadership includes Pulinattu Nandakumar (Director), Sonal Jain (Director), Biju Gopinathan Nair (Managing Director). Past directors included Yogita Maheshwari, Pulinattu Nandakumar, Sonal Jain. It holds ₹9.48 Cr open charges and ₹6.55 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 305, Kailash Tower, Shiv Shristi Complex, Goregaon Link Road, Mulund West,, Mumbai, Maharashtra, 400080.
U24110MH2019PLC319508
319508
14 January 2019
₹5.00 Cr
₹4.02 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Saroja Pharma Industries India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pulinattu Nandakumar | Director | 02 Feb 2023 | Current |
| Sonal Jain | Director | 09 May 2023 | Current |
| Biju Gopinathan Nair | Managing Director | 14 Jan 2019 | Current |
| Anita Sethia | Additional Director | 03 Sep 2025 | Current |
| Santosh Shivram Palav | Additional Director | 09 Oct 2025 | Current |
| Ravindra Shivaji Salaskar | Whole-Time Director | 09 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Cfo | 12 Feb 2025 | Past |
| Pramod Abcsdd | Additional Director | 05 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 10 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 05 May 2023 | Past |
| Pramod Abcsdd | Director | 04 May 2023 | Past |
| Pramod Abcsdd | Director | 04 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Saroja Pharma Industries India Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.02% decrease. The company also saw a slight decrease in profitability, with a 6.97% decrease in profit. The company's net worth Soared by an impressive increase of 26.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Saroja Pharma Industries India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹94,800,000.00
₹65,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2023 | Others | ₹2.80 M | Open |
| 14 Jun 2022 | Others | ₹8.50 Cr | Open |
| 14 Jun 2022 | Others | ₹5.00 M | Open |
| 27 Jan 2022 | Others | ₹2.00 M | Open |
| 23 Jun 2020 | Others | ₹6.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Saroja Pharma Industries India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Saroja Pharma Industries India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saroja Pharma Industries India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Santosh Shivram Palav was appointed as a Additional Director was appointed as a Additional Director on 09 Oct 2025 & has been associated with this company since 2 months 12 days . was recorded as a recent event.
Ravindra Shivaji Salaskar was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 09 Oct 2025 & has been associated with this company since 2 months 12 days . was recorded as a recent event.
Progress on Anita Sethia was appointed as a Additional Director was appointed as a Additional Director on 03 Sep 2025 & has been associated with this company since 3 months 17 days . was documented.
Progress on Saroja Pharma Industries India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others of Rs. 8.50 Cr registered on 14 Jun 2022 with Charge ID 100582764 was modified on 02 Apr 2024. was documented.
The activity Saroja Pharma Industries India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The CIN of Saroja Pharma Industries India Limited is U24110MH2019PLC319508.
Saroja Pharma Industries India Limited is headquartered at 305, Kailash Tower, Shiv Shristi Complex, Goregaon Link Road, Mulund West,, Mumbai, Maharashtra, 400080.
Saroja Pharma Industries India Limited was incorporated on 14 January 2019.
The current directors of Saroja Pharma Industries India Limited are
The primary industry of Saroja Pharma Industries India Limited is Trade.
Saroja Pharma Industries India Limited is unlisted.
The authorized capital of Saroja Pharma Industries India Limited is ₹5.00 Cr, and the paid-up capital is ₹4.02 Cr.
The compliance status of Saroja Pharma Industries India Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX